Described by the company as a superior version of its Elisio dialyzer that was introduced earlier this year, the new model features a state-of-the-art membrane made of Polynephron synthetic fiber that functions in a manner similar to the human kidney. The membrane delivers excellent biocompatibility, hemocompatibility, and solute-removal performance, resulting in superior clearances for better patient outcomes, according to Nipro.

"We have taken a dialyzer that delivers excellent clearance and reduced thrombogenicity, and improved it by eliminating any BPA or DEHP," said Joe Dawson, Senior Vice President, Nipro North America. "Both chemicals are known endocrine disruptors. There are many published studies showing that endocrine disruptors cause adverse effects in animals. As a company that is focused on making products that improve the lives of patients, we are excited that we now have a dialyzer that can do that."

The new polypropylene housing is also around 25% lighter than dialyzers currently available in the market, according to Nipro, thus making disposal and transportation more cost effective. It also generates 25% less resin waste than other commonly used materials, can be molded with lower temperatures, and generates 10% fewer CO₂ emissions during resin production and 50% fewer CO₂ emissions when it is incinerated.

"The eco-friendliness of the Elisio dialyzer is a definite plus," Dawson said. "We do not have to compromise on clinical performance, while making a greener dialyzer."

The global dialysis market was valued at $61.6 billion in 2013 and is expected to reach $83.2 billion by 2018, at a CAGR of 6.2%, according to Research and Markets.